ANCOTIL

This brand name is authorized in Austria, Estonia, France, Ireland, Japan, Malta, Netherlands, Poland, UK.

Active ingredients

The drug ANCOTIL contains one active pharmaceutical ingredient (API):

1	Flucytosine UNII D83282DT06 - FLUCYTOSINE
	Flucytosine is a fluorinated pyrimidine derivative. It is an antimycotic agent exerting fungistatic and fungicidal activity by interfering with protein and DNA synthesis. Fluorodeoxyuridine interferes with the enzyme thymidylate synthase. Inhibition of thymidylate synthase subsequently causes disruption of DNA synthesis.
	Read more about Flucytosine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
Ancotil 2.5 g/250 ml Solution for Infusion	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
ANCOTIL Solution for infusion	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J02AX01	Flucytosine	J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AX Other antimycotics for systemic use
Discover more medicines within J02AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1612527
FR	Base de données publique des médicaments	67250203, 68758674
GB	Medicines & Healthcare Products Regulatory Agency	78410
JP	医薬品医療機器総合機構	6290001F1050
MT	Medicines Authority	AA565/41902, AA565/41903, AA565/41904
NL	Z-Index G-Standaard	15450295
NL	Z-Index G-Standaard, PRK	15989
PL	Rejestru Produktów Leczniczych	100005833